Introduction
============

Laparoscopic colon surgery was first introduced in 1991, and laparoscopic surgery is now widely performed for resecting colorectal cancer.[@b1-ott-9-2203] A Cochrane review showed that laparoscopic surgery was associated with similar oncologic outcomes and short-term benefits, including shorter hospital stay, less postoperative pain, improved cosmesis, and an earlier return to normal activity, as compared with open surgery.[@b2-ott-9-2203],[@b3-ott-9-2203]

However, previous randomized controlled trials excluded patients with transverse colon cancer because the surgical procedures used were dependent on the cancer location, the variable anatomy of the middle colic vessels, which demand excellent surgical skills, and the anatomical location of the transverse colon relative to major organs, especially the pancreas, spleen, and duodenum.[@b4-ott-9-2203]--[@b12-ott-9-2203]

In recent years, with accumulating experience of performing laparoscopic surgery, several studies have evaluated the safety and feasibility of laparoscopic resection of transverse colon cancer.[@b13-ott-9-2203]--[@b19-ott-9-2203] However, the results of these studies should be interpreted carefully because few studies compared the clinical outcome of laparoscopic surgery for transverse colon cancer relative to those of other colon cancers, and these studies enrolled small number of patients, and the duration of follow-up were short.

The aims of the present study were to compare the perioperative, pathologic, and oncologic outcomes of laparoscopic surgery with those of open surgery for the resection of transverse colon cancer and to demonstrate the feasibility of laparoscopic surgery in this setting.

Patients and methods
====================

We retrospectively reviewed the medical records of patients who underwent curative resection of transverse colon cancer at six Hallym University-affiliated hospitals (Kangnam Sacred Heart Hospital, Kangdong Sacred Heart Hospital, Chuncheon Sacred Heart Hospital, Dongtan Sacred Heart Hospital, Hangang Sacred Heart Hospital, and Hallym Sacred Heart Hospital) between January 2005 and February 2015. Patients were divided into two groups according to whether they underwent laparoscopic or open surgery. The study was approved by the Institutional Review Board of Dongtan Sacred Heart hospital (IRB 2015-268-I). As this was a retrospective study patient consent was not required.

Transverse colon cancer was defined as cancer located between the hepatic and splenic flexures. Patients with recurrent disease, familial adenomatous polyposis or hereditary nonpolyposis colorectal cancer, or stage 0 and IV cancer were excluded. Patients undergoing emergency surgery because of perforation and acute obstruction, and patients undergoing palliative resection were also excluded.

Patient demographic characteristics, operative variables, postoperative outcomes, histopathologic variables, and long-term oncologic outcomes were retrieved from the medical records. Patient demographics included age, sex, body mass index (BMI), American Society of Anesthesiologists score, prior surgical history, and cancer location. Operative variables included operation time, intraoperative transfusion, conversion, and procedure type. Postoperative outcomes included the time to flatus, time to soft food intake, postoperative hospital stay, complications, and the mortality rate within 30 days after surgery. The histopathologic report was examined to retrieve the following variables: histologic type of cancer, cancer size, proximal resection margin, distal resection margin, number of harvested lymph nodes, presence of positive lymph nodes, and disease stage (tumor-node-metastasis \[TNM\] classification). Long-term oncologic outcomes included local recurrence, disease-free survival (DFS), and overall survival (OS).

The routine preoperative evaluations included physical examination, serum carcinoembryonic antigen (CEA) concentrations, abdominopelvic and chest computed tomography (CT), and colonoscopy. If necessary, magnetic resonance imaging and positron emission tomography-CT were performed for staging. Preoperative colonoscopic tattooing or clipping was performed if the cancer location was unclear.

Right hemicolectomy was performed for cancers located at the hepatic flexure, and left hemicolectomy was performed for cancers located at the splenic flexure. Transverse colectomy was performed for cancers located between the aforementioned two lesions. Right hemicolectomy was defined as ligation of the ileocolic, right colic, and the right branch of the middle colic vessels at their origins together with lymphadenectomy. If we needed to extend the right hemicolectomy, we ligated the origin of the middle colic vessels. Left hemicolectomy was defined as ligation of the left colic and the left branch of the middle colic vessels at their origins together with lymphadenectomy. If we needed to extend the left hemicolectomy, we ligated the origin of the middle colic vessels. Transverse colectomy was defined as ligation of the origin of the middle colic vessels together with lymphadenectomy. The choice of surgical approach was at the surgeon's discretion. Conversion to an open procedure was defined as an unplanned abdominal incision larger than necessary for specimen retrieval in the laparoscopic group.

Patients were followed up with physical examinations and measurement of serum CEA concentrations every 3 months for the first 2 years, and every 6 months thereafter until 5 years after surgery. Colonoscopy was repeated annually after surgery during the follow-up period. Abdominopelvic and chest CT scans were repeated every 6 months until 5 years. After 5 years, these evaluations were performed annually.

Local recurrence was defined as any recurrence within the anastomotic site. Systemic recurrence was defined as any recurrence outside the anastomotic site. DFS was defined as the time from surgery to disease recurrence or death. OS was defined as the time from surgery to death or the last follow-up date.

Categorical variables are presented as the number and percent of patients, and were analyzed using the *χ*^2^ test or Fisher's exact test. Continuous variables are presented as the mean and standard deviation and were compared using Student's *t*-test or the Mann--Whitney *U* test. DFS and OS were analyzed using the Kaplan--Meier method and were compared using the log-rank test. *P*-values of \<0.05 were considered statistically significant.

Results
=======

A total of 226 patients with transverse colon cancer were included in our study, of whom 122 (54.0%) underwent open surgery and 104 (46.0%) underwent laparoscopic surgery. The patient demographic characteristics are summarized in [Table 1](#t1-ott-9-2203){ref-type="table"}. The mean age of the laparoscopic and open surgery groups was 65.6 and 62.8 years, respectively (*P*=0.113). There were no significant differences in the proportion of males, BMI, American Society of Anesthesiologists score, and history of prior surgery. The cancer was located in the proximal transverse colon in 141 patients (62.4%), the middle transverse colon in 31 patients (13.7%), and the distal transverse colon in 54 patients (23.9%); the site distribution was similar in both groups (*P*=0.107).

The operative variables are shown in [Table 2](#t2-ott-9-2203){ref-type="table"}. The mean operation time was longer in the laparoscopic group than in the open group (267.3 vs 172.7 minutes, respectively, *P*\<0.001), but the frequency of intraoperative transfusion was similar in both groups (*P*=0.151). Transverse colectomy was more frequently performed in the open group (13.1% vs 2.9%, respectively), whereas left hemicolectomy was more frequently performed in the laparoscopic group (27.9% vs 17.2%, respectively). There were six (5.8%) conversions from laparoscopic surgery to open surgery because of bleeding in two patients, severe adhesion in three patients, and a fixed tumor mass in one patient.

The postoperative outcomes are shown in [Table 3](#t3-ott-9-2203){ref-type="table"}. Although the time to flatus was similar in both groups, the time to soft food intake (6.0 vs 6.6 days, respectively, *P*=0.036) and the postoperative hospital stay (13.2 vs 15.7 days, respectively, *P*=0.018) were shorter in the laparoscopic group than in the open group. Complications were more frequent in the open group than in the laparoscopic group, although the difference was not statistically significant (20.5% vs 11.5%, respectively, *P*=0.070). There were no differences between the two groups in terms of wound complications, ileus, postoperative bleeding, anastomotic leakage, and intra-abdominal abscess, but pulmonary complications were more frequent in the laparoscopic group than in the open group (5.7% vs 0%, *P*=0.016). There were no postoperative deaths in either group.

Cancer size, proximal and distal resection margins, histologic type, and TNM stage were similar in both groups. The number of harvested lymph nodes was significantly greater in the open group than in the laparoscopic group (24.3 vs 20.3, respectively, *P*\<0.001). According to the TNM classification, patients in the laparoscopic group tended to have earlier-stage disease compared with patients in the open group, although the difference was not statistically significant (*P*=0.068) ([Table 4](#t4-ott-9-2203){ref-type="table"}).

The mean duration of follow-up was 46 and 54 months in the laparoscopic and open groups, respectively. The 5-year OS rates were 90.8% and 88.6% in the laparoscopic and open groups, respectively (*P*=0.540) ([Figure 1A](#f1-ott-9-2203){ref-type="fig"}). Subgroup analysis of stage II and III transverse colon cancer patients revealed that the 5-year OS was not significantly different between the laparoscopic and open groups in stage II patients (81.3% vs 86.1%, *P*=0.817) or stage III patients (81.2% vs 68.1%, *P*=0.301) ([Figure 1B and C](#f1-ott-9-2203){ref-type="fig"}). The 5-year DFS rates were 86.1% and 78.9% in the laparoscopic and open groups, respectively (*P*=0.201) ([Figure 2A](#f2-ott-9-2203){ref-type="fig"}). In a subgroup analysis of stage II and III patients, the 5-year DFS was not significantly different between the laparoscopic and open groups in stage II patients (65.7% vs 67.4%, *P*=0.471) or stage III patients (69.2% vs 62.8%, *P*=0.314) ([Figure 2B and C](#f2-ott-9-2203){ref-type="fig"}). Disease recurrence occurred in a similar number of patients in the laparoscopic and open groups (12.5% vs 18.0%, *P*=0.252). The most common site of recurrence was the peritoneum, followed by the liver, lung, small bowel, abdominal lymph nodes, rectum, stomach, brain, and incision site ([Table 5](#t5-ott-9-2203){ref-type="table"}).

Discussion
==========

Several randomized controlled trials have demonstrated that laparoscopic surgery provides favorable short-term outcomes and similar long-term oncologic outcomes compared with open surgery for the resection of colon cancer.[@b4-ott-9-2203]--[@b12-ott-9-2203] However, transverse colon cancer was excluded from the previous trials for several reasons. First, the type of surgical procedure and the extent of lymph node dissection vary according to the cancer's location. Second, laparoscopic surgery for transverse colon cancer requires excellent surgical skills owing to the technical difficulty of lymph node dissection around the middle colic vessels, and the anatomical variations of the middle colic vessels.[@b15-ott-9-2203],[@b19-ott-9-2203],[@b20-ott-9-2203] Mobilization of the transverse colon involves dissection around critical organs such as the duodenum, pancreas, and spleen, and the base of the mesenteric vessels, which may result in serious complications if dissection occurs along the wrong plane.[@b21-ott-9-2203] Finally, surgeons have limited experience of treating transverse colon cancer because its accounts for only \~10% of all colon cancers.[@b22-ott-9-2203]--[@b24-ott-9-2203]

With accumulating experience of laparoscopic surgery and continued developments in laparoscopic instruments, several studies have examined the safety and feasibility of laparoscopic surgery for resecting transverse colon cancer.[@b13-ott-9-2203]--[@b19-ott-9-2203] In addition, several studies have reported the long-term oncologic outcomes of laparoscopic surgery.[@b25-ott-9-2203]--[@b28-ott-9-2203]

The present study reported that the time to soft diet and the postoperative hospital stay were significantly shorter in the laparoscopic group than in the open group. These results are consistent with those of previous studies.[@b13-ott-9-2203]--[@b15-ott-9-2203],[@b17-ott-9-2203],[@b29-ott-9-2203]

The postoperative complication rate was not significantly different between the two groups in prior studies, even though laparoscopic surgery requires excellent surgical skills for resecting transverse colon cancer.[@b13-ott-9-2203]--[@b17-ott-9-2203],[@b25-ott-9-2203]--[@b28-ott-9-2203] Nakashima et al[@b29-ott-9-2203] reported that the postoperative complication rate was significantly lower in the laparoscopic group than in the open group (6% vs 36%, *P*\<0.01). In the present study, the complication rate tended to be lower in the laparoscopic group (11.5% vs 20.5%, *P*=0.070). Of note, the rate of pulmonary complications was significantly lower in the laparoscopic group than in the open group (0% vs 5.7%, *P*=0.016), which partly explains the observed difference in the overall complication rate between the two groups.

In the present study, the operation time was much longer in laparoscopic group than in the open group, as in previous studies.[@b13-ott-9-2203]--[@b17-ott-9-2203],[@b19-ott-9-2203] In addition, previous studies reported that operation time for laparoscopic surgery was longer for procedures involving the transverse colon than for other sites of the colon.[@b14-ott-9-2203],[@b18-ott-9-2203] These results may reflect the difficulty of performing laparoscopic surgery for transverse colon cancer and the need for extensive resection.

The principle for colon cancer surgery is en bloc resection of the colon to leave clear proximal and distal margins. In the present study, the cancer size, proximal margin, and distal margin were similar in both groups. However, the number of harvested lymph nodes was greater in the open group than in the laparoscopic group (24.3 vs 20.3, *P*=0.019). Akiyoshi et al[@b14-ott-9-2203] also reported a greater number of harvested lymph nodes in their open resection group than in their laparoscopic resection group (23 vs 17, *P*\<0.01). A systematic review demonstrated that the number of harvested lymph nodes is associated with survival and recommended that the surgeon should harvest at least 12 lymph nodes for adequate sampling.[@b30-ott-9-2203] The mean number of harvested lymph nodes in the laparoscopic group was 20, which exceeds the recommended number of lymph node for adequate sampling.[@b30-ott-9-2203]

In previous studies, the 5-year OS ranged from 61% to 94.3% and from 59% to 88.6% in the laparoscopic and open groups,[@b25-ott-9-2203]--[@b28-ott-9-2203] while 5-year DFS ranged from 70.5% to 80.4% and from 66.7% to 85.7%, respectively.[@b25-ott-9-2203]--[@b28-ott-9-2203] In the present study, the 5-year OS and DFS were 90.8% and 86.1%, respectively, in the laparoscopic group, and 88.6% and 78.9%, respectively, in the open group, which are within the ranges reported in the previous studies. Furthermore, the present study showed that the oncologic outcomes of laparoscopic surgery were comparable with those of open surgery in terms of the 5-year OS and DFS (*P*=0.540 and *P*=0.201, respectively).

Laparoscopic surgery for the resection of transverse colon cancer by experienced surgeons is associated with favorable short-term outcomes, especially faster recovery and shorter hospital stay, and equivalent long-term outcomes, including 5-year OS and DFS, relative to open surgery. These results demonstrate that laparoscopic surgery is an acceptable method for resecting transverse colon cancer.

The present study had several limitations. First, this study was performed retrospectively, which may introduce selection bias. In particular, the surgeons tended to perform laparoscopic surgery in patients with early-stage transverse colon cancer, whereas open surgery was preferred for advanced-stage cancer (*P*=0.068). Second, although the number of laparoscopic surgical procedures for resecting transverse colon in our study (\>100) was greater than that in previous studies,[@b13-ott-9-2203]--[@b16-ott-9-2203],[@b19-ott-9-2203],[@b25-ott-9-2203]--[@b27-ott-9-2203] the low incidence of transverse colon cancer limits the opportunity for prospective randomized clinical trials, which are needed to establish definitive conclusions. Despite these limitations, we believe that our results provide valuable support for laparoscopic resection of transverse colon cancer. A larger scaled, prospective, randomized controlled study is needed to confirm the safety and efficacy of laparoscopic resection of transverse colon cancer.

Conclusion
==========

The present study has shown that laparoscopic surgery is associated with several perioperative benefits and similar oncologic outcomes relative to open surgery for the resection of transverse colon cancer. Therefore, we believe that laparoscopic surgery can be safely performed for the resection of transverse colon cancer.
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###### 

Patient characteristics

  Variables             Open surgery (n=123)   Laparoscopic surgery (n=103)   *P*-value
  --------------------- ---------------------- ------------------------------ -----------
  Age, years            62.8 (14.0)            65.6 (12.1)                    0.113
  Age \>60, n (%)       91 (74.6)              83 (79.8)                      0.353
  Male, n (%)           66 (54.1)              68 (65.4)                      0.085
  BMI, kg/m^2^          23.1 (3.1)             23.5 (4.0)                     0.399
  ASA, n (%)                                                                  0.548
   1                    20 (16.4)              20 (19.4)                      
   2                    80 (65.6)              58 (56.3)                      
   3                    21 (17.2)              24 (23.3)                      
   4                    1 (0.8)                1 (1.0)                        
  Previous op history   21 (17.2)              23 (22.1)                      0.354
  Tumor location                                                              0.107
   Proximal             74 (60.7)              67 (64.4)                      
   Middle               22 (18.0)              9 (8.7)                        
   Distal               26 (21.3)              28 (26.9)                      

**Note:** Data are presented as the number of patients (%) or mean (standard deviation) unless otherwise stated.

**Abbreviations:** BMI, body mass index; ASA, American Society of Anesthesiologists; Op, operation.

###### 

Operative outcome according to type of surgery

  Variables                 Open surgery (n=123)   Laparoscopic surgery (n=103)   *P*-value
  ------------------------- ---------------------- ------------------------------ -----------
  Operation time, minutes   172.7 (54.0)           267.3 (74.8)                   \<0.001
  Transfusion               21 (17.2)              26 (25.0)                      0.151
  Procedures                                                                      0.007
   Right hemicolectomy      85 (69.7)              72 (69.2)                      
   Transverse colectomy     16 (13.1)              3 (2.9)                        
   Left hemicolectomy       21 (17.2)              29 (27.9)                      
  Conversion                                       6 (5.8)                        
  Mortality, n (%)          0 (0)                  0 (0)                          NA

**Note:** Data are presented as the number of patients (%) or mean (standard deviation) unless otherwise stated.

**Abbreviation:** NA, not available.

###### 

Postoperative outcome

  Variables                        Open surgery (n=123)   Laparoscopic surgery (n=103)   *P*-value
  -------------------------------- ---------------------- ------------------------------ -----------
  Time to flatus, days             4.5 (1.7)              4.5 (1.2)                      0.716
  Time to soft food intake, days   6.6 (2.2)              6.0 (1.6)                      0.036
  Duration of POD, days            15.7 (9.7)             13.2 (5.6)                     0.018
  Complications, n (%)             25 (20.5)              12 (11.5)                      0.070
   Wound                           2 (1.6)                2 (1.9)                        1.000
   Ileus                           8 (6.6)                6 (5.8)                        1.000
   Pulmonary                       7 (5.7)                0 (0)                          0.016
   Postoperative bleeding          7 (5.7)                2 (1.9)                        0.184
   Anastomotic leakage             2 (2.5)                1 (1.0)                        0.626
   Intrabdominal abscess           2 (1.6)                3 (2.9)                        0.663
   Complications ≥2                4 (3.3)                2 (1.9)                        0.689

**Note:** Data are presented as the number of patients (%) or median (standard deviation) unless otherwise stated.

**Abbreviations:** POD, postoperative days; n, number.

###### 

Pathologic outcome

  Variables                          Open surgery (n=123)   Laparoscopic surgery (n=103)   *P*-value
  ---------------------------------- ---------------------- ------------------------------ -----------
  Tumor size, cm                     5.3 (3.0)              5.0 (2.6)                      0.328
  PRM, cm                            16.8 (10.1)            15.7 (9.5)                     0.413
  DRM, cm                            10.3 (6.7)             10.5 (12.7)                    0.847
  No of harvested LN                 24.3 (15.5)            20.3 (9.8)                     0.019
  Proportion of positive LN, n (%)   47 (38.5)              32 (30.8)                      0.223
  TNM stage, n (%)                                                                         0.068
   I                                 18 (14.6)              26 (25.2)                      
   II                                58 (47.5)              45 (43.3)                      
   III                               47 (38.5)              32 (30.8)                      
  Histologic type, n (%)                                                                   0.635
   Well                              45 (36.9)              45 (43.3)                      
   Moderate                          57 (46.7)              45 (43.3)                      
   Poor                              10 (8.2)               5 (4.8)                        
   Mucinous                          11 (8.9)               8 (7.8)                        

**Note:** Data are presented as the number of patients (%) or median (standard deviation) unless otherwise stated.

**Abbreviations:** PRM, proximal resection margin; DRM, distal resection margin; No, number; LN, lymph node; TNM, tumor-node-metastasis.

###### 

Kaplan--Meier survival curve comparing local recurrence, DFS and OS

  Variables               Open surgery (n=123)   Laparoscopic surgery (n=103)   *P*-value
  ----------------------- ---------------------- ------------------------------ -----------
  5-year OS                                                                     
   Stage all              88.6%                  90.8%                          0.540
   Stage II               86.1%                  81.3%                          0.817
   Stage III              68.1%                  81.2%                          0.301
  5-year DFS                                                                    
   Stage all              78.9%                  86.1%                          0.201
   Stage II               67.4%                  65.7%                          0.471
   Stage III              62.8%                  69.2%                          0.314
  Recurrence, n (%)       22 (18.0)              13 (12.5)                      0.252
   Anastomotic site       0                      1                              
   Peritoneum             5                      4                              
   Liver                  5                      3                              
   Lung                   3                      4                              
   Small bowel            4                      2                              
   Abdominal lymph node   3                      1                              
   Rectum                 2                      0                              
   Stomach                2                      0                              
   Brain                  1                      0                              
   Incision site          0                      1                              
   Ovary                  1                      0                              
   Recurrent site ≥2      4                      5                              

**Abbreviations:** DFS, disease-free survival; OS, overall survival.
